Gene · 64783
Papers2,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactylation increases the stability of RBM15 to drives m6A modification in non-small-cell lung cancer cells. | FASEB J | 2025 | 40135634 | PubTator, text mining | PubMed |
| RBM15, an m6A enzyme, suppresses NLRP3 inflammasome activation in rheumatoid arthritis through macrophage metabolism. | Clin Exp Rheumatol | 2025 | 40095631 | PubTator, text mining | PubMed |
| Insights From m6A RNA Methylation: Biomarkers for Diagnosis of Acute Myocardial Infarction. | J Inflamm Res | 2025 | 40093945 | PubTator, text mining | PubMed |
| A m6A writer RBM15 enhances the cell malignancy of osteosarcoma by mediating m6A modification of lncRNA THAP9-AS1. | Exp Cell Res | 2025 | 40015502 | PubTator, text mining | PubMed |
| RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3/CBR3-AS1/miR-409-3p/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer. | J Transl Med | 2025 | 39962467 | PubTator, text mining | PubMed |
| RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39928150 | PubTator, text mining | PubMed |
| m6A Methylation Regulator RBM15-Mediated Upregulation of ITGBL1 mRNA Stability Aggravates Colon Adenocarcinoma Progression by Remodeling the Tumor Microenvironment. | Turk J Gastroenterol | 2025 | 39840822 | PubTator, text mining | PubMed |
| Recognizing SARS-CoV-2 infection of nasopharyngeal tissue at the single-cell level by machine learning method. | Mol Immunol | 2025 | 39700903 | PubTator, text mining | PubMed |
| Comprehensive Analysis of RNA Methylation-Regulated Gene Signature and Immune Infiltration in Ischemia/Reperfusion-Induced Acute Kidney Injury. | Kidney Blood Press Res | 2025 | 39600181 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification of PERP by RBM15 Enhances the Tumorigenesis of Lung Adenocarcinoma via p53 Signaling Pathway. | Mol Biotechnol | 2025 | 39556280 | PubTator, text mining | PubMed |
| RBM15 promotes lipogenesis and malignancy in gastric cancer by regulating N6-Methyladenosine modification of ACLY mRNA in an IGF2BP2-dependent manner. | Biochim Biophys Acta Mol Cell Biol Lipids | 2025 | 39549859 | PubTator, text mining | PubMed |
| RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. | Oncogene | 2025 | 39528815 | PubTator, text mining | PubMed |
| RBM15-mediated the m6A modification of MAT2A promotes osteosarcoma cell proliferation, metastasis and suppresses ferroptosis. | Mol Cell Biochem | 2025 | 39527319 | PubTator, text mining | PubMed |
| RBM15 Drives Breast Cancer Cell Progression and Immune Escape via m6A-Dependent Stabilization of KPNA2 mRNA. | Clin Breast Cancer | 2025 | 39488447 | PubTator, text mining | PubMed |
| Integrative Analysis Reveals Differential Characteristics of DDR1 Mutant and Wild-type Gastric Cancers and Constructs their Prediction Models. | Curr Med Chem | 2025 | 39421995 | PubTator, text mining | PubMed |
| RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin. | Biochem Genet | 2025 | 38429603 | PubTator, text mining | PubMed |
| Myeloid sarcoma with RBM15::MRTFA (MKL1) mimicking vascular neoplasm. | Virchows Arch | 2025 | 38374236 | PubTator, text mining | PubMed |
| RNA Metabolism and the Role of Small RNAs in Regulating Multiple Aspects of RNA Metabolism. | Noncoding RNA | 2024 | 39846679 | PubTator, text mining | PubMed |
| High expression of RBM15 is associated with better prognosis in esophageal squamous cell carcinoma. | J Gastrointest Oncol | 2024 | 39816010 | PubTator, text mining | PubMed |
| RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells. | Mol Med | 2024 | 39716068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64783/papers?page=6